financetom
Business
financetom
/
Business
/
ZKH Group Swings to Q4 Adjusted Earnings as Revenue Increases -- Shares Advance Premarket
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ZKH Group Swings to Q4 Adjusted Earnings as Revenue Increases -- Shares Advance Premarket
Mar 19, 2024 4:15 AM

06:46 AM EDT, 03/19/2024 (MT Newswires) -- ZKH Group ( ZKH ) reported Q4 adjusted earnings Tuesday of 0.45 renminbi ($0.06) per diluted American depositary share, swinging from a loss of 2.17 renminbi a year earlier.

Revenue for the quarter ended Dec. 31 was 2.44 billion renminbi, up from 2.26 billion renminbi a year earlier.

Comparable analyst estimates were not available.

Shares of the Chinese maintenance, repair, and operations platform were up nearly 4% in recent Tuesday premarket activity.

Price: 19.99, Change: +0.74, Percent Change: +3.84

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
BioMarin Pharma Q2 revenue beats estimates
BioMarin Pharma Q2 revenue beats estimates
Aug 4, 2025
Overview * BioMarin Q2 2025 revenue rises 16% yr/yr, beating analyst expectations * Non-GAAP diluted EPS for Q2 beats estimates, rising 50% yr/yr * Co completes acquisition of Inozyme, adding BMN 401 to enzyme therapies Outlook * BioMarin raises full-year 2025 revenue guidance to $3.125 bln-$3.200 bln * Company expects 2025 Non-GAAP EPS of $4.40 to $4.55 * BioMarin sees...
Tactile Systems Q2 revenue beats estimates
Tactile Systems Q2 revenue beats estimates
Aug 4, 2025
Overview * Tactile Systems ( TCMD ) Q2 revenue rises 7.8% yr/yr, beating analyst expectations, per LSEG data * Adjusted EBITDA for Q2 beats estimates, reaching $7.7 mln * Net income declines to $3.2 mln from $4.3 mln in Q2 2024 Outlook * Company expects 2025 revenue between $310 mln and $315 mln * Tactile Systems ( TCMD ) projects...
Paymentus Q2 revenue up 41.9%, beats analyst expectations
Paymentus Q2 revenue up 41.9%, beats analyst expectations
Aug 4, 2025
Overview * Paymentus Q2 2025 revenue rises 41.9% yr/yr, beating analyst expectations * Adjusted EBITDA for Q2 2025 grows 40.7%, with a 33.9% margin * Co processed 175.8 mln transactions, up 25.2% from Q2 2024 Outlook * Paymentus ( PAY ) forecasts Q3 revenue between $278 mln and $282 mln * Company expects fiscal 2025 revenue between $1,123 mln and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved